2025
Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study
Savitz S, Stevens M, Nath B, D'Onofrio G, Melnick E, Jeffery M. Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study. JMIR Formative Research 2025, 9: e66596. PMID: 40537088, DOI: 10.2196/66596.Peer-Reviewed Original ResearchConceptsIncidence rate ratiosLong-term opioid therapyIn-person careMental illness cohortOpioid use disorderIn-personTelemedicine visitsChronic painPain medicineOpioid therapyEmergency medicineMental healthFamily practiceHealth service usageChronic opioidsPercentage of visitsIn-Person VisitsIn-person treatmentPoor outcomeAdministrative claims dataUse disorderMedicare Advantage patientsOptumLabs Data WarehouseVulnerable patient populationCare deliveryInterconnections of Multimorbidity‐Related Clinical Outcomes: Analysis of Health Administrative Claims Data With a Dynamic Network Approach
Mei H, Xiao H, Shia B, Qiao G, Li Y. Interconnections of Multimorbidity‐Related Clinical Outcomes: Analysis of Health Administrative Claims Data With a Dynamic Network Approach. Statistics In Medicine 2025, 44: e70125. PMID: 40384542, DOI: 10.1002/sim.70125.Peer-Reviewed Original ResearchConceptsMultimorbidity managementOptimize health resources allocationDisease-specific clinical outcomesBurden of multimorbidityHealth policy developmentHealth resource allocationShape treatment strategiesAdministrative claims dataEvidence-based supportClaims dataMultimorbidityClinical outcomesBreast cancerPolicy developmentNetwork approachMedical dataClinical insightsExtensive simulationsOutcomesFrequent challengeRelevant network structuresTime-varying interconnectionsResource allocationRising complexityNetworkDifferences in patterns of outpatient epilepsy‐specific medication initiation after acute ischemic stroke in the Medicare population
Donahue M, Brooks J, Hsu J, Price M, Blacker D, Schwamm L, Newhouse J, Westover M, Haneuse S, Moura L. Differences in patterns of outpatient epilepsy‐specific medication initiation after acute ischemic stroke in the Medicare population. Epilepsia 2025 PMID: 40184019, DOI: 10.1111/epi.18396.Peer-Reviewed Original ResearchNon-Hispanic whitesOlder age groupsAcute ischemic strokeAge groupsCommunity-dwelling beneficiariesNon-Hispanic white beneficiariesUS Medicare beneficiariesCumulative incidenceYear of dischargeUS geographic regionsAdministrative claims dataUS census divisionsIschemic strokeHospitalization causeRacial/Ethnic DifferencesMedicare beneficiariesOlder adultsWhite beneficiariesBlack/African AmericanMedicare populationClaims dataHispanic beneficiariesHospital regionMedication initiationInpatient readmissions
2024
By Any Other Name: Bowel Dysfunction After Proctectomy for Cancer and Its Predictive Factors in Administrative Databases
Leeds I, Coppersmith N, Moore M, Saleh A, Cruickshank K, Pantel H, Reddy V, Mongiu A. By Any Other Name: Bowel Dysfunction After Proctectomy for Cancer and Its Predictive Factors in Administrative Databases. Journal Of Surgical Research 2024, 303: 342-351. PMID: 39413695, DOI: 10.1016/j.jss.2024.09.027.Peer-Reviewed Original ResearchBowel dysfunctionRehabilitation proceduresPredictive factorsCosts of healthcare utilizationAssociated with bowel dysfunctionPopulation-based studyNeoadjuvant chemotherapy administrationLow anterior resection syndromeLow anterior resectionAdministrative claims dataRetrospective cohort studyAnterior resection syndromePostoperative bowel dysfunctionHealthcare utilizationPoisson regressionDiagnostic codesFollowed surgeryChemoradiation therapyFollow-up costsMultiagent chemotherapyStatistically significant covariatesAnterior resectionClaims dataCohort studyIndependent predictorsIncorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure
Kyanko K, Sahay K, Wang Y, Li S, Schreiber M, Hager M, Myers R, Johnson W, Zhang J, Krumholz H, Suter L, Triche E. Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure. JAMA Network Open 2024, 7: e2414431. PMID: 38829614, PMCID: PMC11148674, DOI: 10.1001/jamanetworkopen.2024.14431.Peer-Reviewed Original ResearchConceptsCenters for Medicare & Medicaid ServicesSpecialty subgroupsPerformance quintileMedicare AdvantageReadmission ratesRisk-standardized readmission ratesHospital-wide readmission measureHospital outcome measuresTest-retest reliabilityRisk-adjustment variablesMeasurement reliabilityAdministrative claims dataReadmission measuresImprove measurement reliabilityIntegrated Data RepositoryMA beneficiariesQuintile rankingsMedicare beneficiariesMedicaid ServicesAll-CausePublic reportingStudy assessed differencesClaims dataOutcome measuresMA cohort
2023
Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014
Sankar A, Everhart A, Jena A, Jeffery M, Ross J, Shah N, Karaca-Mandic P. Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014. The Joint Commission Journal On Quality And Patient Safety 2023, 49: 458-466. PMID: 37380503, DOI: 10.1016/j.jcjq.2023.05.003.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseFDA safety communicationPhysician characteristicsLabel prescribingCare physiciansTestosterone prescribingService administrative claims dataNon-primary care physiciansCertain physician characteristicsDrug Administration (FDA) safety communicationPrimary care physiciansAdministrative claims dataCase mix indexTestosterone therapyArtery diseaseTestosterone prescriptionsPrescribing levelsMean agePrescription trendsTeaching hospitalClaims dataPrescription levelsMedicare feePrescribingUS FoodFrequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States
Naidu S, Sutton M, Gao W, Fine J, Xie J, Desai N, Owens A. Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States. Journal Of Medical Economics 2023, 26: 682-690. PMID: 37170479, DOI: 10.1080/13696998.2023.2208966.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathyDefinitive diagnosisHypertrophic cardiomyopathyHCM diagnosisMedicare Supplemental databasesIBM MarketScan CommercialEmergency room visitsAdministrative claims dataMisclassification of patientsEligible patientsMarketScan CommercialMost patientsRoom visitsAlternative diagnosesPotential misdiagnosesCardiovascular conditionsInappropriate treatmentDatabase studyClaims dataHealthcare costsDiagnostic journeyPatientsEconomic burdenCurrent studyDiagnostic historyEvaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes
Jiang D, Herrin J, Van Houten H, McCoy R. Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes. JAMA Network Open 2023, 6: e2250602. PMID: 36662531, PMCID: PMC9860518, DOI: 10.1001/jamanetworkopen.2022.50602.Peer-Reviewed Original ResearchConceptsHigh-deductible health plansSevere hypoglycemiaED visitsHealth plansCohort studyHDHP enrollmentPotential treatment selection biasAcute diabetes complicationsGlucose-lowering medicationsRetrospective cohort studyOptimal diabetes careAdministrative claims dataTreatment selection biasMixed effects logistic regression modelsLogistic regression modelsGlycemic complicationsGlycemic controlPatient ageDiabetes complicationsDiabetes careHospital visitsStudy populationInverse propensity scoreMAIN OUTCOMEClaims data
2022
Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Miller PE, Bromfield SG, Ma Q, Crawford G, Whitney J, DeVries A, Desai NR. Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA Internal Medicine 2022, 182: 926-933. PMID: 35849410, PMCID: PMC9295019, DOI: 10.1001/jamainternmed.2022.2735.Peer-Reviewed Original ResearchConceptsIntra-aortic balloon pumpPercutaneous coronary interventionKidney replacement therapyAcute myocardial infarctionCardiogenic shockClinical outcomesLVAD useVentricular assist deviceBalloon pumpRetrospective propensity-matched cohort studyAssist deviceAcute Myocardial Infarction ComplicatedPropensity-matched cohort studyTotal health care costsMyocardial Infarction ComplicatedPropensity-matched analysisPropensity-matched pairsLong-term outcomesRisk of mortalityAdministrative claims dataHealth care costsIABP useIndex admissionCohort studyCoronary interventionThirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries
Reinhardt SW, Clark KAA, Xin X, Parzynski CS, Riello R, Sarocco P, Ahmad T, Desai NR. Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries. Circulation Cardiovascular Quality And Outcomes 2022, 15: e008069. PMID: 35861780, DOI: 10.1161/circoutcomes.121.008069.Peer-Reviewed Original ResearchConceptsHypertensive heart diseaseIndex hospitalizationMedicare beneficiariesPost-acute care spendingService administrative claims dataMedicare Bundled PaymentsHeart failure admissionsHeart failure hospitalizationPrimary discharge diagnosisChronic kidney diseaseAdministrative claims dataCare spendingPostacute care spendingSkilled nursing facilitiesCare Improvement ProgramDrivers of costDiastolic HFHF careHF hospitalizationSystolic HFFailure hospitalizationDischarge diagnosisKidney diseaseObservation staysPostacute careSimplified Machine Learning Models Can Accurately Identify High-Need High-Cost Patients With Inflammatory Bowel Disease
Nguyen N, Patel S, Gabunilas J, Qian A, Cecil A, Jairath V, Sandborn W, Ohno-Machado L, Chen P, Singh S. Simplified Machine Learning Models Can Accurately Identify High-Need High-Cost Patients With Inflammatory Bowel Disease. Clinical And Translational Gastroenterology 2022, 13: e00507. PMID: 35905414, PMCID: PMC10476830, DOI: 10.14309/ctg.0000000000000507.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseUnplanned healthcare utilizationAdult patientsBowel diseaseHealthcare utilizationHealthcare costsLogistic regressionRetrospective cohort studyNationwide Readmissions DatabaseIdentification of patientsAdministrative claims dataHigh-cost patientsHNHC patientsCohort studyHospitalized patientsClaims dataHigh riskPatientsTraditional logistic regressionDerivation dataMean AUCIBDMean areaCharacteristic curveDiseaseCorrection to: Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data
Mintz J, Duprey MS, Zullo AR, Lee Y, Kiel DP, Daiello LA, Rodriguez KE, Venkatesh AK, Berry SD. Correction to: Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data. The Journals Of Gerontology Series A 2022, 77: 2147-2147. PMID: 35532361, PMCID: PMC9536433, DOI: 10.1093/gerona/glac098.Peer-Reviewed Original ResearchPayer-Level Care Coordination and Re-admission to Acute Mental Health Care for Uninsured Individuals
Proctor SL, Gursky-Landa B, Kannarkat JT, Guimaraes J, Newcomer JW. Payer-Level Care Coordination and Re-admission to Acute Mental Health Care for Uninsured Individuals. The Journal Of Behavioral Health Services & Research 2022, 49: 385-396. PMID: 35194730, DOI: 10.1007/s11414-022-09789-1.Peer-Reviewed Original ResearchConceptsAcute care episodeCare coordinationCare episodesAcute mental health careCare coordination programAcute care servicesLong-term outcomesAcute care settingAdministrative claims dataMental health careSafety net systemUsual careCare settingsClaims dataCare servicesUninsured individualsCoordination programHealth careCarePatientsResidential servicesEpisodesReduced ratesSignificant cost savingsCost savings
2021
Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
Sankar A, Swanson KM, Zhou J, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration. JAMA Network Open 2021, 4: e2136662. PMID: 34851398, PMCID: PMC8637256, DOI: 10.1001/jamanetworkopen.2021.36662.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAmbulatory CareAnti-Bacterial AgentsBronchitisCross-Sectional StudiesDrug LabelingDrug PrescriptionsFemaleFluoroquinolonesHealth Plan ImplementationHumansInterrupted Time Series AnalysisMaleMedicareMiddle AgedPractice Patterns, Physicians'SinusitisUnited StatesUnited States Food and Drug AdministrationUrinary Tract InfectionsConceptsPrescribing of fluoroquinolonesCross-sectional studyBlack box warningFDA warningCare physiciansPrescribing levelsBox warningMAIN OUTCOMEUS FoodDrug AdministrationMedicare administrative claims dataUncomplicated urinary tract infectionsNon-primary care physiciansAcute care visitsUrinary tract infectionFDA black box warningPrimary care physiciansAdministrative claims dataCase mix indexFluoroquinolone prescriptionsPrescribing trendsCare visitsPrescribing ratesTract infectionsOutpatient visitsClinical Characteristics and Perioperative Complication Profiles of COVID-19–Positive Patients Undergoing Hip Fracture Surgery
Galivanche AR, Mercier MR, Schneble CA, Brand J, Pathak N, Varthi AG, Rubin LE, Grauer JN. Clinical Characteristics and Perioperative Complication Profiles of COVID-19–Positive Patients Undergoing Hip Fracture Surgery. JAAOS Global Research And Reviews 2021, 5: e21.00104. PMID: 34653097, PMCID: PMC8522872, DOI: 10.5435/jaaosglobal-d-21-00104.Peer-Reviewed Original ResearchConceptsHip fracture surgeryCOVID-19 positive patientsMinor adverse eventsAdverse eventsCOVID-19 positivityFracture surgeryHigh incidenceCOVID-19 positive groupCOVID-19 positive statusCOVID-19-negative groupGeriatric hip fracture surgeryPerioperative complication profilePostoperative adverse eventsHip fracture patientsSerious adverse eventsPatient risk factorsAdministrative claims dataCOVID-19 infectionAdverse event informationOngoing global pandemicClinical characteristicsFracture patientsPostoperative eventsPreoperative variablesPropensity matchingReal-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment. JAMA Network Open 2021, 4: e2130587. PMID: 34677594, PMCID: PMC8536955, DOI: 10.1001/jamanetworkopen.2021.30587.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsSecondary end pointsMyocardial infarctionClinical trialsCardiovascular diseaseProstate cancerCardiovascular eventsEnd pointRisk of MACELarge US administrative claims databasePropensity-matched cohort studyUS administrative claims databasePropensity score-matched patientsAdverse cardiovascular eventsPrimary end pointAdministrative claims databaseProportional hazards regressionRandomized clinical trialsAdministrative claims dataTrial eligibility criteriaMedicare Advantage beneficiariesProstate cancer treatmentReal-world evidenceElectronic health recordsCardiovascular outcomesIdentification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data
Mintz J, Duprey MS, Zullo AR, Lee Y, Kiel DP, Daiello LA, Rodriguez KE, Venkatesh AK, Berry SD. Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data. The Journals Of Gerontology Series A 2021, 77: 1421-1429. PMID: 34558615, PMCID: PMC9255678, DOI: 10.1093/gerona/glab274.Peer-Reviewed Original ResearchConceptsFall-related injuriesClaims-based algorithmHip fractureMore fall-related injuriesLong-stay NH residentsCause of morbidityAdministrative claims dataNursing home residentsMedicare Part AInjury reduction effortsRetrospective cohortIntracranial bleedNH residentsRisk factorsInjury codesHome residentsClaims dataInjuryPhi correlation coefficientExternal causesAdministrative dataStudy purposePart AProvider claimsCauseIncorporating Present-on-Admission Indicators in Medicare Claims to Inform Hospital Quality Measure Risk Adjustment Models
Triche EW, Xin X, Stackland S, Purvis D, Harris A, Yu H, Grady JN, Li SX, Bernheim SM, Krumholz HM, Poyer J, Dorsey K. Incorporating Present-on-Admission Indicators in Medicare Claims to Inform Hospital Quality Measure Risk Adjustment Models. JAMA Network Open 2021, 4: e218512. PMID: 33978722, PMCID: PMC8116982, DOI: 10.1001/jamanetworkopen.2021.8512.Peer-Reviewed Original ResearchConceptsPOA indicatorRisk factorsOutcome measuresQuality outcome measuresRisk-adjustment modelsClaims dataAdmission indicatorsPatient risk factorsAcute myocardial infarctionPatient-level outcomesAdministrative claims dataQuality improvement studyClaims-based measuresComparative effectiveness studiesPatient claims dataInternational Statistical ClassificationMortality outcome measuresRelated Health ProblemsHospital quality measuresRisk model performanceHospital stayIndex admissionCare algorithmHeart failureMortality outcomesEffects of forced disruption in Medicaid managed care on children with asthma
Piwnica‐Worms K, Staiger B, Ross JS, Rosenthal MS, Ndumele CD. Effects of forced disruption in Medicaid managed care on children with asthma. Health Services Research 2021, 56: 668-676. PMID: 33624290, PMCID: PMC8313960, DOI: 10.1111/1475-6773.13643.Peer-Reviewed Original ResearchConceptsPrimary care providersPersistent asthmaCare plansOutpatient visitsCare utilizationCare administrative claims dataEmergency department utilizationHealth care utilizationAdministrative claims dataIndicators of asthmaProportion of childrenPatients outpatientHealth utilizationAdministrative claimsAsthmaCare providersClaims dataNumber of childrenConsistent associationMedicaidVisitsChildrenOutpatientsPercentage point decreaseEnrollment dataComparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
McCoy RG, Van Houten HK, Deng Y, Mandic PK, Ross JS, Montori VM, Shah ND. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019. JAMA Network Open 2021, 4: e2035792. PMID: 33523188, PMCID: PMC7851726, DOI: 10.1001/jamanetworkopen.2020.35792.Peer-Reviewed Original ResearchConceptsSodium-glucose cotransporter 2 inhibitorsDipeptidyl peptidase-4 inhibitorsCommercial insurance beneficiariesMedicare Advantage beneficiariesDPP-4i treatmentGLP-1RAsType 2 diabetesInsurance beneficiariesMedicare AdvantageGlucose levelsGlucagonlike Peptide-1 Receptor AgonistsPeptide-1 receptor agonistsHealth plansCommercial health insurance plansGLP-1RA treatmentRetrospective cohort studyCotransporter 2 inhibitorsInitiation of treatmentPeptidase-4 inhibitorsLow-income patientsSeparate logistic regression modelsAdministrative claims dataCommercial health plansAdjusted annual rateLogistic regression models
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply